[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Metronidazole.]
[M03AB01, succinylcholine, The therapeutic efficacy of Succinylcholine can be increased when used in combination with Metronidazole.]
[J01EC02, sulfadiazine, The metabolism of Sulfadiazine can be decreased when combined with Metronidazole.]
[J01EC01, sulfamethoxazole, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Sulfamethoxazole.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Sulfisoxazole.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Sulpiride.]
[N03AX03, sulthiame, The therapeutic efficacy of Sulthiame can be decreased when used in combination with Metronidazole.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Metronidazole.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Metronidazole.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Metronidazole.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Metronidazole.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Metronidazole.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Tetracaine.]
[N05AE05, lurasidone, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lurasidone.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Metronidazole.]
[N04BC07, apomorphine, The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Metronidazole.]
[L04AX02, thalidomide, The risk or severity of peripheral neuropathy can be increased when Thalidomide is combined with Metronidazole.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Metronidazole.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Eribulin.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Metronidazole.]
[N05CA19, thiopental, The therapeutic efficacy of Thiopental can be decreased when used in combination with Metronidazole.]
[N05AC02, thioridazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Thiothixene.]
[S01ED01, timolol, The risk or severity of QTc prolongation can be increased when Timolol is combined with Metronidazole.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Metronidazole.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Metronidazole.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Metronidazole.]
[N06AF04, tranylcypromine, The metabolism of Metronidazole can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Metronidazole.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Metronidazole.]
[S01BA05, triamcinolone, The metabolism of Metronidazole can be increased when combined with Triamcinolone.]
[N05CD05, triazolam, The metabolism of Metronidazole can be decreased when combined with Triazolam.]
[R03BA07, mometasone, The metabolism of Metronidazole can be increased when combined with Mometasone.]
[A03AA05, trimebutine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Metronidazole.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be decreased when combined with Metronidazole.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Metronidazole.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Metronidazole.]
[J01FA08, troleandomycin, The metabolism of Metronidazole can be decreased when combined with Troleandomycin.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be increased when used in combination with Metronidazole.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Metronidazole.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Metronidazole.]
[A10BH05, linagliptin, The metabolism of Linagliptin can be decreased when combined with Metronidazole.]
[J05AP03, boceprevir, The metabolism of Metronidazole can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Telaprevir can be decreased when combined with Metronidazole.]
[J05AG05, rilpivirine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Rilpivirine.]
[N03AX21, ezogabine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ezogabine.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Metronidazole.]
[R03AC18, indacaterol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Indacaterol.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Metronidazole.]
[C08DA01, verapamil, The metabolism of Metronidazole can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Metronidazole can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Metronidazole.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Metronidazole.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Metronidazole.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Metronidazole.]
[J05AF01, zidovudine, The metabolism of Metronidazole can be increased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Metronidazole can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Metronidazole.]
[L01EC01, vemurafenib, The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Metronidazole.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Metronidazole.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Metronidazole.]
[R03DC01, zafirlukast, The metabolism of Zafirlukast can be decreased when combined with Metronidazole.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Metronidazole.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Metronidazole.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Metronidazole.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Metronidazole.]
[G04BD07, tolterodine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Tolterodine.]
[J02AC03, voriconazole, The metabolism of Metronidazole can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be increased when used in combination with Metronidazole.]
[S01FA01, atropine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Atropine.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Metronidazole.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Metronidazole.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Metronidazole.]
[H02AB11, prednylidene, The metabolism of Metronidazole can be increased when combined with Prednylidene.]
[G04BE10, avanafil, The metabolism of Avanafil can be decreased when combined with Metronidazole.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Metronidazole.]
[G04BD12, mirabegron, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Metronidazole can be decreased when combined with Cobicistat.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Metronidazole.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Metronidazole.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Metronidazole.]
[N05CA04, barbital, The therapeutic efficacy of Barbital can be decreased when used in combination with Metronidazole.]
[J05AE04, nelfinavir, The metabolism of Metronidazole can be decreased when combined with Nelfinavir.]
[C08CA13, lercanidipine, The metabolism of Metronidazole can be decreased when combined with Lercanidipine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Metronidazole.]
[N03AX22, perampanel, The therapeutic efficacy of Perampanel can be decreased when used in combination with Metronidazole.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Metronidazole.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Metronidazole.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Pasireotide.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Metronidazole.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Metronidazole.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Metronidazole.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Metronidazole.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Bedaquiline.]
[C04AX11, bencyclane, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Bencyclane.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Metronidazole.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Metronidazole.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Moxifloxacin.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Metronidazole.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Metronidazole.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Metronidazole.]
[L01EC02, dabrafenib, The metabolism of Dabrafenib can be decreased when combined with Metronidazole.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Metronidazole.]
[C08EA02, bepridil, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Bepridil.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Metronidazole.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Metronidazole.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Metronidazole.]
[N03AF04, eslicarbazepine, The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Metronidazole.]
[N03AG04, vigabatrin, The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Metronidazole.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Metronidazole.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Metronidazole.]
[A16AA07, metreleptin, The metabolism of Metronidazole can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Metronidazole can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The metabolism of Metronidazole can be increased when combined with Betamethasone.]
[V03AB34, fomepizole, The metabolism of Metronidazole can be decreased when combined with Fomepizole.]
[L04AC11, siltuximab, The metabolism of Metronidazole can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Metronidazole.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Metronidazole.]
[A03BA03, hyoscyamine, The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Metronidazole.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Metronidazole.]
[R03AC19, olodaterol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Olodaterol.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Metronidazole.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Metronidazole.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Metronidazole.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Metronidazole.]
[J05AP09, dasabuvir, The metabolism of Metronidazole can be decreased when combined with Dasabuvir.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Metronidazole.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Metronidazole.]
[N06AX11, mirtazapine, The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Metronidazole.]
[L04AC10, secukinumab, The metabolism of Metronidazole can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Metronidazole.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lenvatinib.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Metronidazole.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Metronidazole.]
[N02BE01, acetaminophen, The metabolism of Metronidazole can be decreased when combined with Acetaminophen.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Metronidazole is combined with Tioclomarol.]
[C01EB17, ivabradine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ivabradine.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Metronidazole.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Metronidazole.]
[S01EC01, acetazolamide, The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Metronidazole.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Metronidazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Metronidazole.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be decreased when combined with Metronidazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Metronidazole.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be decreased when combined with Metronidazole.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Metronidazole.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Metronidazole.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Metronidazole.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Metronidazole.]
[A10BB31, acetohexamide, The metabolism of Acetohexamide can be decreased when combined with Metronidazole.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Metronidazole.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Metronidazole.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Metronidazole.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Metronidazole.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Metronidazole.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Metronidazole.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Metronidazole.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Bupivacaine.]
[C07AA19, bupranolol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Bupranolol.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Metronidazole.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Buserelin.]
[N05BE01, buspirone, The metabolism of Metronidazole can be decreased when combined with Buspirone.]
[L01AB01, busulfan, The serum concentration of Busulfan can be increased when it is combined with Metronidazole.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Arsenic trioxide.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Artemether.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Metronidazole.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Metronidazole.]
[L01XK03, rucaparib, The metabolism of Metronidazole can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Metronidazole.]
[L01EF02, ribociclib, The metabolism of Ribociclib can be decreased when combined with Metronidazole.]
[N07XX16, deutetrabenazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Metronidazole.]
[N03AX30, beclamide, The therapeutic efficacy of Beclamide can be decreased when used in combination with Metronidazole.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Oxybuprocaine.]
[J05AE09, tipranavir, The risk or severity of adverse effects can be increased when Metronidazole is combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Metronidazole.]
[L04AB02, infliximab, The metabolism of Metronidazole can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Midostaurin can be decreased when combined with Metronidazole.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Metronidazole.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Delafloxacin.]
[L01BC06, capecitabine, The serum concentration of the active metabolites of Capecitabine can be increased when Capecitabine is used in combination with Metronidazole.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Metronidazole.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Metronidazole.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Vorinostat.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Metronidazole.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Metronidazole.]
[J05AG03, efavirenz, The metabolism of Metronidazole can be increased when combined with Efavirenz.]
[R03BA02, budesonide, The metabolism of Metronidazole can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Metronidazole.]
[J05AX18, letermovir, The metabolism of Metronidazole can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Acetyldigoxin.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Capsaicin.]
[A10BK04, ertugliflozin, The metabolism of Metronidazole can be decreased when combined with Ertugliflozin.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Acrivastine.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Macimorelin.]
[L02BB05, apalutamide, The metabolism of Apalutamide can be decreased when combined with Metronidazole.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Metronidazole.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Carbinoxamine.]
[R05CB03, carbocysteine, The risk or severity of adverse effects can be increased when Metronidazole is combined with Carbocisteine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Metronidazole.]
[B02BX09, fostamatinib, The metabolism of Metronidazole can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Metronidazole can be decreased when combined with Cannabidiol.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Encorafenib.]
[C07AB08, celiprolol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Celiprolol.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Metronidazole.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be decreased when combined with Metronidazole.]
[N03AX17, stiripentol, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Metronidazole.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Metronidazole.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Metronidazole.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Metronidazole.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Metronidazole.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Metronidazole.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Metronidazole.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Inotersen.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Metronidazole.]
[L04AA39, emapalumab, The metabolism of Metronidazole can be increased when combined with Emapalumab.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Metronidazole.]
[L01XJ03, glasdegib, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Metronidazole is combined with Amifampridine.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be decreased when combined with Metronidazole.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Cibenzoline.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Metronidazole.]
[P02BX04, triclabendazole, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Metronidazole.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Metronidazole.]
[N06AX29, brexanolone, The therapeutic efficacy of Brexanolone can be decreased when used in combination with Metronidazole.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Metronidazole.]
[N05BA09, clobazam, The therapeutic efficacy of Clobazam can be decreased when used in combination with Metronidazole.]
[H02AB14, cloprednol, The metabolism of Metronidazole can be increased when combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Candesartan can be decreased when combined with Metronidazole.]
[L04AB01, etanercept, The metabolism of Metronidazole can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Metronidazole can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Metronidazole.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Metronidazole.]
[C03BX03, cicletanine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Cicletanine.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Entrectinib.]
[N07XX11, pitolisant, Metronidazole may increase the QTc-prolonging activities of Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Metronidazole.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Metronidazole.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Metronidazole.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Metronidazole.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Metronidazole.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Metronidazole.]
[G03AC09, desogestrel, The metabolism of Metronidazole can be increased when combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Metronidazole.]
[N03AX25, cenobamate, The serum concentration of Metronidazole can be decreased when it is combined with Cenobamate.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Metronidazole.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Dexchlorpheniramine.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Metronidazole.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Metronidazole.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Metronidazole.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Metronidazole can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Metronidazole.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Metronidazole.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Metronidazole.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Metronidazole.]
[N02CC06, eletriptan, The metabolism of Metronidazole can be increased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Rofecoxib can be decreased when combined with Metronidazole.]
[L01XF03, bexarotene, The metabolism of Bexarotene can be decreased when combined with Metronidazole.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Metronidazole.]
[N03AG02, dipropylacetamide, The therapeutic efficacy of Valpromide can be decreased when used in combination with Metronidazole.]
[S03AA08, chloramphenicol, The metabolism of Metronidazole can be decreased when combined with Chloramphenicol.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Chlorcyclizine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Metronidazole.]
[D07XB03, fluprednidene, The metabolism of Metronidazole can be increased when combined with Fluprednidene.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Metronidazole.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Dyclonine.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Metronidazole.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ebastine.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Fostemsavir.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Metronidazole.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Metronidazole.]
[L01EX23, pralsetinib, The metabolism of Metronidazole can be decreased when combined with Pralsetinib.]
[R06AB04, chlorpheniramine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Metronidazole.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Metronidazole.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Chlorprothixene.]
[M03BB03, chlorzoxazone, The metabolism of Metronidazole can be decreased when combined with Chlorzoxazone.]
[N06BX18, vinpocetine, The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Metronidazole.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Metronidazole.]
[B06AC06, berotralstat, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Berotralstat.]
[A16AX20, lonafarnib, The serum concentration of Lonafarnib can be increased when it is combined with Metronidazole.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Relugolix.]
[N03AX10, felbamate, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Felbamate.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Metronidazole.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Flumequine.]
[R03CC15, formoterol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Formoterol.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Metronidazole.]
[A02BA01, cimetidine, The metabolism of Metronidazole can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The therapeutic efficacy of Gabapentin can be decreased when used in combination with Metronidazole.]
[N07CA02, cinnarizine, The metabolism of Metronidazole can be decreased when combined with Cinnarizine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Cinoxacin.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Metronidazole.]
[S03AA07, ciprofloxacin, The metabolism of Metronidazole can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Citalopram.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Metronidazole.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Metronidazole is combined with Fexinidazole.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mobocertinib.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Clemastine.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Metronidazole.]
[A10BB12, glimepiride, The metabolism of Glimepiride can be decreased when combined with Metronidazole.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Metronidazole.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Metronidazole.]
[L01EA06, asciminib, The metabolism of Metronidazole can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Metronidazole can be decreased when combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Metronidazole.]
[J04BA01, clofazimine, The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Metronidazole.]
[C10AB01, clofibrate, The metabolism of Metronidazole can be decreased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Metronidazole can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Metronidazole.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be decreased when used in combination with Metronidazole.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Metronidazole.]
[C01EB24, mavacamten, The metabolism of Mavacamten can be decreased when combined with Metronidazole.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Metronidazole.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Metronidazole.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Granisetron.]
[N05AH02, clozapine, The metabolism of Metronidazole can be decreased when combined with Clozapine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Metronidazole can be increased when combined with Bimekizumab.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Metronidazole.]
[L04AA13, leflunomide, The metabolism of Leflunomide can be decreased when combined with Metronidazole.]
[N01AB07, desflurane, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Desflurane.]
[C04AX28, ifenprodil, The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Metronidazole.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Metronidazole.]
[J01FA15, telithromycin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Telithromycin.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Desloratadine.]
[M01AH03, valdecoxib, The metabolism of Valdecoxib can be decreased when combined with Metronidazole.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Metronidazole.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Metronidazole.]
[J02AC02, itraconazole, The metabolism of Metronidazole can be decreased when combined with Itraconazole.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Emedastine.]
[L01EA01, imatinib, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Imatinib.]
[J02AC04, posaconazole, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Posaconazole.]
[C08CA09, lacidipine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lacidipine.]
[N03AX09, lamotrigine, The metabolism of Metronidazole can be increased when combined with Lamotrigine.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Levocabastine.]
[S01BA03, cortisone, The metabolism of Metronidazole can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lomefloxacin.]
[H02AB15, meprednisone, The metabolism of Metronidazole can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mequitazine.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Adenosine.]
[R06AE03, cyclizine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Cyclizine.]
[C03DA04, eplerenone, The metabolism of Metronidazole can be decreased when combined with Eplerenone.]
[N05AD03, metylperon, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Melperone.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Metronidazole.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Metronidazole.]
[N06BA07, modafinil, The metabolism of Metronidazole can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Metronidazole.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Metronidazole.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Metronidazole.]
[C03XA02, conivaptan, The metabolism of Conivaptan can be decreased when combined with Metronidazole.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Metronidazole.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Metronidazole.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Metronidazole.]
[L01DB02, daunorubicin, The metabolism of Metronidazole can be increased when combined with Daunorubicin.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Metronidazole.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Metronidazole.]
[N03AG06, tiagabine, The therapeutic efficacy of Tiagabine can be decreased when used in combination with Metronidazole.]
[M03AC11, cisatracurium, Metronidazole may increase the neuromuscular blocking activities of Cisatracurium.]
[N06AB10, escitalopram, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Escitalopram.]
[G04BD08, solifenacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Solifenacin.]
[N06AA01, desipramine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Desipramine.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Oxaliplatin.]
[N03AF02, oxcarbazepine, The metabolism of Metronidazole can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Metronidazole can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Metronidazole.]
[L04AB04, adalimumab, The metabolism of Metronidazole can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Metronidazole can be decreased when combined with Gefitinib.]
[N06BA02, dextroamphetamine, The metabolism of Metronidazole can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Metronidazole.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Metronidazole.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Metronidazole.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Metronidazole.]
[N03AX07, phenacemide, The therapeutic efficacy of Phenacemide can be decreased when used in combination with Metronidazole.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Phenol.]
[N03AD02, phensuximide, The therapeutic efficacy of Phensuximide can be decreased when used in combination with Metronidazole.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Cinchocaine.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Metronidazole.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Metronidazole.]
[A03AX04, pinaverium, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Pinaverium.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be decreased when combined with Metronidazole.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Metronidazole.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Metronidazole.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be decreased when combined with Metronidazole.]
[C08CA03, isradipine, The risk or severity of QTc prolongation can be increased when Isradipine is combined with Metronidazole.]
[D07XC04, diflucortolone, The metabolism of Metronidazole can be increased when combined with Difluocortolone.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Metronidazole.]
[C01AA05, digoxin, The risk or severity of QTc prolongation can be increased when Digoxin is combined with Metronidazole.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Metronidazole.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Metronidazole.]
[N02AA03, hydromorphone, The metabolism of Hydromorphone can be decreased when combined with Metronidazole.]
[J05AE08, atazanavir, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Atazanavir.]
[B01AC21, treprostinil, The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Metronidazole.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Metronidazole can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Dimenhydrinate.]
[N03AG05, progabide, The therapeutic efficacy of Progabide can be decreased when used in combination with Metronidazole.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Metronidazole.]
[A03FA02, cisapride, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Cisapride.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Metronidazole.]
[C01BA03, disopyramide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Disopyramide.]
[P03AA04, disulfiram, The risk or severity of psychotic reaction can be increased when Disulfiram is combined with Metronidazole.]
[N07XX02, riluzole, The therapeutic efficacy of Riluzole can be decreased when used in combination with Metronidazole.]
[N05AX08, risperidone, The risk or severity of QTc prolongation can be increased when Risperidone is combined with Metronidazole.]
[R06AE09, levocetirizine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Metronidazole.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Metronidazole.]
[A04AD12, aprepitant, The metabolism of Metronidazole can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Metronidazole.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Metronidazole.]
[G04BE08, tadalafil, The metabolism of Metronidazole can be decreased when combined with Tadalafil.]
[S01BC05, ketorolac, The metabolism of Ketorolac can be decreased when combined with Metronidazole.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Metronidazole.]
[C01EB18, ranolazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ranolazine.]
[R03AC12, salmeterol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Salmeterol.]
[A03FA03, domperidone, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Domperidone.]
[N06AA16, dothiepin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Dosulepin.]
[N06AA12, doxepin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Doxepin.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Metronidazole.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Metronidazole.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Metronidazole.]
[N01AB08, sevoflurane, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Sevoflurane.]
[N05AD08, droperidol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Droperidol.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Metronidazole.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Sultopride.]
[C07AB13, talinolol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Talinolol.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Temafloxacin.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Metronidazole.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Metronidazole.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Terodiline.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Metronidazole.]
[N06BA09, atomoxetine, The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Metronidazole.]
[N03AX11, topiramate, The therapeutic efficacy of Topiramate can be decreased when used in combination with Metronidazole.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Toremifene.]
[C03CA04, torsemide, The metabolism of Torasemide can be decreased when combined with Metronidazole.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Triptorelin.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Metronidazole.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Metronidazole.]
[S01GX10, epinastine, The risk or severity of QTc prolongation can be increased when Epinastine is combined with Metronidazole.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Metronidazole.]
[N03AX15, zonisamide, The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Metronidazole.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Metronidazole.]
[C01BG01, moricizine, The risk or severity of QTc prolongation can be increased when Moricizine is combined with Metronidazole.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be decreased when combined with Metronidazole.]
[N03AG01, valproic acid, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Valproic acid.]
[S01AA17, erythromycin, The metabolism of Metronidazole can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be decreased when used in combination with Metronidazole.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Metronidazole.]
[J04AK02, ethambutol, The metabolism of Metronidazole can be decreased when combined with Ethambutol.]
[R03BA05, fluticasone, The metabolism of Metronidazole can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Metronidazole.]
[L02AA03, ethinyl estradiol, The metabolism of Metronidazole can be increased when combined with Ethinylestradiol.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ibutilide.]
[N03AD01, ethosuximide, The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Metronidazole.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be decreased when used in combination with Metronidazole.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Etidocaine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Metronidazole.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ajmaline.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Metronidazole.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Fleroxacin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Metronidazole.]
[R06AX12, terfenadine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Terfenadine.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Metronidazole.]
[N06AB08, fluvoxamine, The metabolism of Metronidazole can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Encainide.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Leuprolide.]
[M01CB01, gold sodium thiomalate, The metabolism of Metronidazole can be decreased when combined with Sodium aurothiomalate.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Metronidazole.]
[C08CA02, felodipine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Fendiline.]
[N03AX26, fenfluramine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Metronidazole.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Metronidazole.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Salbutamol.]
[C01BC04, flecainide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Flecainide.]
[J02AC01, fluconazole, The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Metronidazole.]
[J02AX01, flucytosine, The serum concentration of Flucytosine can be increased when it is combined with Metronidazole.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Metronidazole.]
[N05CD03, flunitrazepam, The metabolism of Metronidazole can be decreased when combined with Flunitrazepam.]
[D07AC08, fluocinonide, The metabolism of Metronidazole can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Metronidazole can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of adverse effects can be increased when Metronidazole is combined with Ethanol.]
[L01BC02, fluorouracil, The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.]
[N06AB03, fluoxetine, The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Metronidazole.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Flupentixol.]
[N05CD01, flurazepam, The metabolism of Metronidazole can be decreased when combined with Flurazepam.]
[S01BC04, flurbiprofen, The metabolism of Metronidazole can be decreased when combined with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Fluspirilene.]
[L02BB01, flutamide, The metabolism of Metronidazole can be decreased when combined with Flutamide.]
[L01BC03, tegafur, The serum concentration of Tegafur can be increased when it is combined with Metronidazole.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be increased when used in combination with Metronidazole.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Metronidazole.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Amisulpride.]
[N06DA04, galantamine, The risk or severity of QTc prolongation can be increased when Galantamine is combined with Metronidazole.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be increased when used in combination with Metronidazole.]
[C08DA02, gallopamil, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Gallopamil.]
[N03AA04, barbexaclone, The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Metronidazole.]
[C10AB04, gemfibrozil, The metabolism of Metronidazole can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Telavancin.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Degarelix.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Metronidazole.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Metronidazole.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Metronidazole.]
[N03AD03, methsuximide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Methsuximide.]
[N01AH02, alfentanil, The metabolism of Metronidazole can be decreased when combined with Alfentanil.]
[L01EH01, lapatinib, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Metronidazole.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Metronidazole.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Metronidazole.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Metronidazole.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Metronidazole.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Metronidazole.]
[C07AB09, esmolol, The risk or severity of QTc prolongation can be increased when Esmolol is combined with Metronidazole.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Metronidazole.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Goserelin.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Haloperidol.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Metronidazole.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Histrelin.]
[N05AH04, quetiapine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Quetiapine.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Metronidazole.]
[C09CA01, losartan, The risk or severity of QTc prolongation can be increased when Losartan is combined with Metronidazole.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Metronidazole.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Metronidazole.]
[J05AG01, nevirapine, The metabolism of Metronidazole can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Nilvadipine.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Oxatomide.]
[C03AA03, hydrochlorothiazide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Metronidazole can be increased when combined with Hydrocortisone.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Metronidazole.]
[P01BA02, hydroxychloroquine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Hydroxychloroquine.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Hydroxyzine.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Metronidazole.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Metronidazole.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Metronidazole.]
[N06AA02, imipramine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Metronidazole.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Terlipressin.]
[M03BX02, tizanidine, The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Metronidazole.]
[C03BA11, indapamide, The risk or severity of QTc prolongation can be increased when Indapamide is combined with Metronidazole.]
[S01BC01, indomethacin, The metabolism of Metronidazole can be decreased when combined with Indomethacin.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Articaine.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be decreased when combined with Metronidazole.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Metronidazole.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Metronidazole.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Metronidazole.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be decreased when combined with Metronidazole.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Anagrelide.]
[N01AB06, isoflurane, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Metronidazole.]
[J04AC01, isoniazid, The metabolism of Metronidazole can be decreased when combined with Isoniazid.]
[L04AC07, tocilizumab, The metabolism of Metronidazole can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Metronidazole.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Metronidazole.]
[J02AB02, ketoconazole, The metabolism of Metronidazole can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Metronidazole.]
[V03AC03, deferasirox, The metabolism of Metronidazole can be decreased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Metronidazole can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mizolastine.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Amantadine is combined with Metronidazole.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Metronidazole.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Metronidazole.]
[G03AD01, levonorgestrel, The metabolism of Metronidazole can be decreased when combined with Levonorgestrel.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Lidocaine.]
[C08EX01, lidoflazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lidoflazine.]
[N06BA13, armodafinil, The metabolism of Metronidazole can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Metronidazole.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Metronidazole.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Metronidazole.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Metronidazole.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Metronidazole.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Metronidazole.]
[L01EA03, nilotinib, The metabolism of Nilotinib can be decreased when combined with Metronidazole.]
[N06AA21, maprotiline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Maprotiline.]
[P02CA01, mebendazole, The risk or severity of adverse effects can be increased when Mebendazole is combined with Metronidazole.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be decreased when used in combination with Metronidazole.]
[P01BC02, mefloquine, The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Metronidazole.]
[N06DX01, memantine, The metabolism of Metronidazole can be decreased when combined with Memantine.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Metronidazole.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Metronidazole.]
[N03AA01, mephobarbital, The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Metronidazole.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Mepivacaine.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Dolasetron.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Metronidazole.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be decreased when used in combination with Metronidazole.]
[H03BB02, methimazole, The metabolism of Metronidazole can be decreased when combined with Methimazole.]
[N05CA15, methohexital, The therapeutic efficacy of Methohexital can be decreased when used in combination with Metronidazole.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Metronidazole.]
[N05AA02, methotrimeprazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Methotrimeprazine.]
[D05BA02, methoxsalen, The metabolism of Metronidazole can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Metronidazole.]
[V04CG05, methylene blue, The metabolism of Metronidazole can be decreased when combined with Methylene blue.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Metronidazole.]
[N03AF03, rufinamide, The therapeutic efficacy of Rufinamide can be decreased when used in combination with Metronidazole.]
[N02CA04, methysergide, The metabolism of Methysergide can be decreased when combined with Metronidazole.]
[A03FA01, metoclopramide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Metoclopramide.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Pipemidic acid.]
[R03BA09, fluticasone furoate, The metabolism of Metronidazole can be decreased when combined with Fluticasone furoate.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Nalidixic acid.]
[V04CD01, metyrapone, The metabolism of Metronidazole can be decreased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Metronidazole can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Metronidazole.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Metronidazole.]
[G03XB01, mifepristone, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Valsartan can be decreased when combined with Metronidazole.]
[C01BD01, amiodarone, The metabolism of Amiodarone can be decreased when combined with Metronidazole.]
[N06AA09, amitriptyline, The metabolism of Metronidazole can be decreased when combined with Amitriptyline.]
[N02AA01, morphine, The metabolism of Morphine can be decreased when combined with Metronidazole.]
[L04AB05, certolizumab pegol, The metabolism of Metronidazole can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Metronidazole can be decreased when combined with Eltrombopag.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Metronidazole.]
[L04AA06, mycophenolic acid, The serum concentration of Mycophenolic acid can be decreased when it is combined with Metronidazole.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be increased when used in combination with Metronidazole.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be decreased when used in combination with Metronidazole.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Metronidazole.]
[N06AA17, amoxapine, The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Metronidazole.]
[N03AB05, fosphenytoin, The serum concentration of Metronidazole can be decreased when it is combined with Fosphenytoin.]
[L04AC03, anakinra, The metabolism of Metronidazole can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Metronidazole can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Metronidazole.]
[A10BG01, troglitazone, The metabolism of Metronidazole can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Metronidazole.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Metronidazole.]
[L02BG04, letrozole, The metabolism of Metronidazole can be decreased when combined with Letrozole.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Metronidazole.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Levosimendan.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Metronidazole.]
[C08CA04, nicardipine, The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Metronidazole.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Metronidazole.]
[N07BA01, nicotine, The metabolism of Metronidazole can be decreased when combined with Nicotine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Metronidazole.]
[C08CA06, nimodipine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Nimodipine.]
[C08CA07, nisoldipine, The metabolism of Metronidazole can be decreased when combined with Nisoldipine.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Metronidazole.]
[C08CA08, nitrendipine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Nitrendipine.]
[N05CF03, zaleplon, The therapeutic efficacy of Zaleplon can be decreased when used in combination with Metronidazole.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Metronidazole.]
[S01AE02, norfloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Norfloxacin.]
[C02KX01, bosentan, The metabolism of Bosentan can be decreased when combined with Metronidazole.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Metronidazole.]
[H01CB02, octreotide, The risk or severity of QTc prolongation can be increased when Octreotide is combined with Metronidazole.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Metronidazole can be increased when combined with Rilonacept.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Oxolinic acid.]
[N02AA05, oxycodone, The metabolism of Metronidazole can be decreased when combined with Oxycodone.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Metronidazole.]
[N05AH05, asenapine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Asenapine.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be increased when used in combination with Metronidazole.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Papaverine.]
[N05CC05, paraldehyde, The therapeutic efficacy of Paraldehyde can be decreased when used in combination with Metronidazole.]
[H02AB05, paramethasone, The metabolism of Metronidazole can be increased when combined with Paramethasone.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Metronidazole.]
[N05AG03, penfluridol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Penfluridol.]
[N05CA01, pentobarbital, The metabolism of Metronidazole can be increased when combined with Pentobarbital.]
[C08EX02, perhexiline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Perhexiline.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Metronidazole.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Metronidazole is combined with Phenindione.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Pheniramine.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Metronidazole.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Metronidazole.]
[M02AA01, phenylbutazone, The metabolism of Phenylbutazone can be decreased when combined with Metronidazole.]
[N03AB02, phenytoin, The serum concentration of Metronidazole can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Metronidazole can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Levofloxacin.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Metronidazole.]
[C08CX01, mibefradil, The metabolism of Metronidazole can be decreased when combined with Mibefradil.]
[S01EB01, pilocarpine, The metabolism of Metronidazole can be decreased when combined with Pilocarpine.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Metronidazole.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Metronidazole.]
[J05AE01, saquinavir, The metabolism of Metronidazole can be decreased when combined with Saquinavir.]
[S01BC06, piroxicam, The metabolism of Piroxicam can be decreased when combined with Metronidazole.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Grepafloxacin.]
[J05AG02, delavirdine, The metabolism of Metronidazole can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Metronidazole.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Metronidazole.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be decreased when combined with Metronidazole.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Metronidazole.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Metronidazole.]
[L04AC08, canakinumab, The metabolism of Metronidazole can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The risk or severity of adverse effects can be increased when Ritonavir is combined with Metronidazole.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Metronidazole.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Metronidazole.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Prajmaline.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Metronidazole.]
[H02AB07, prednisone, The metabolism of Metronidazole can be increased when combined with Prednisone.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Antazoline.]
[C01DX02, prenylamine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Prenylamine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Primaquine.]
[N03AA03, primidone, The metabolism of Metronidazole can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Metronidazole can be decreased when combined with Probenecid.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Probucol.]
[C01BA02, procainamide, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Procainamide.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Procaine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Metronidazole.]
[N05AB04, prochlorperazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Prochlorperazine.]
[G03DA04, progesterone, The metabolism of Metronidazole can be decreased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Metronidazole.]
[R06AD02, promethazine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Promethazine.]
[C01BC03, propafenone, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Propafenone.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Metronidazole.]
[N01AX10, propofol, The risk or severity of QTc prolongation can be increased when Propofol is combined with Metronidazole.]
[C07AA05, propranolol, The metabolism of Metronidazole can be decreased when combined with Propranolol.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Metronidazole.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Metronidazole.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Metronidazole.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Metronidazole is combined with Dalfampridine.]
[P02CC01, pyrantel, The therapeutic efficacy of Pyrantel can be increased when used in combination with Metronidazole.]
[R06AC01, pyrilamine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Mepyramine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Metronidazole.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Metronidazole.]
[P01BC01, quinine, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Quinine.]
[C02AA02, reserpine, The metabolism of Metronidazole can be increased when combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Metronidazole can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Roxithromycin.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Metronidazole.]
[N05CA06, secobarbital, The therapeutic efficacy of Secobarbital can be decreased when used in combination with Metronidazole.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Metronidazole.]
[C07AA07, sotalol, The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Sotalol.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Metronidazole.]
